Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort descending
May
17
2024
White Smoke: Habemus Proposed Rule Making on Marijuana Rescheduling! Bradley Arant Boult Cummings LLP
Feb
7
2022
Feeling Thirsty? Wall Street, Industry Giants Stir Renewed Interest in the CBD-Beverage Market Bradley Arant Boult Cummings LLP
May
12
2022
MORE Than Meets the Eye? How Federal Marijuana Legalization Legislation Could Affect Employers Bradley Arant Boult Cummings LLP
Nov
2
2022
Alabama Medical Cannabis Application Window Is Open: [Insert Michael Scott “It’s Happening” Gif] Bradley Arant Boult Cummings LLP
Jan
3
2023
A Way Too Early Prediction: Alabama Cannabis 2.0 Bradley Arant Boult Cummings LLP
Jan
24
2023
Removing the Green Tax: Congress Can Bring Cannabis Tax Policy in Line with Cannabis Enforcement Policy Bradley Arant Boult Cummings LLP
Mar
30
2023
The Short-Term Consequences of Alabama’s Cannabis Social Equity Policy Bradley Arant Boult Cummings LLP
Jul
13
2023
Highly Legal: Will Congress Legalize Mushrooms Before Marijuana? Bradley Arant Boult Cummings LLP
Aug
8
2023
Alabama Medical Cannabis Update: August 10 Appears to Be the Day Bradley Arant Boult Cummings LLP
Mar
19
2024
Veep Urges DEA to Reschedule Marijuana “As Quickly as Possible” Bradley Arant Boult Cummings LLP
Apr
3
2024
The “Fix” Is In: Alabama Legislature to Consider Controversial Proposal to Revamp Stalled Medical Cannabis Program Bradley Arant Boult Cummings LLP
Apr
6
2022
Don’t Fire Me! I’m Drug Free! It Was CBD! Indiana Court Examines Termination for Use of Hemp Oil Bradley Arant Boult Cummings LLP
Apr
22
2022
Letter from the Editors: What a Long, Strange Trip It’s Been Bradley Arant Boult Cummings LLP
May
5
2022
Assessing the Playing Field After Mississippi’s Medical Cannabis Opt-Out Deadline Expires Bradley Arant Boult Cummings LLP
Jan
17
2023
Is Texas Getting Ready to Expand Its Compassionate Use Program? Bradley Arant Boult Cummings LLP
Mar
14
2023
Insurance Options for Cannabis Businesses Slowly Improving Bradley Arant Boult Cummings LLP
Apr
20
2023
Searching for Claim Support in a Patent Specification? You Better Blaze a Trail Bradley Arant Boult Cummings LLP
Sep
12
2023
It’s Time to Move On: Litigation Regarding Alabama Medical Cannabis Commission Needs to Come to a Head Bradley Arant Boult Cummings LLP
Jan
16
2024
Groundhog Day: Alabama Dispensary, Integrated Licenses Delayed (Again) Bradley Arant Boult Cummings LLP
May
7
2024
Now That It Appears Marijuana Is Being Rescheduled, How Does That Process Work? Bradley Arant Boult Cummings LLP
Apr
19
2022
COVID and CBD Prove to be a Powder Keg for Federal Regulators Bradley Arant Boult Cummings LLP
Aug
30
2022
Delta-8: What Is and What Should Never Be Bradley Arant Boult Cummings LLP
Nov
16
2022
Off to the Races: Executive Order Allows Use of Medical Marijuana in Kentucky Bradley Arant Boult Cummings LLP
Jan
3
2023
2022, Who Were You? A Recap of Hot Issues in 2022. Bradley Arant Boult Cummings LLP
Nov
8
2023
Rocky Top Update – A Summary of the Tennessee Medical Cannabis Commission’s October Meeting Bradley Arant Boult Cummings LLP
Jan
4
2024
Not So Fast My Friend: Alabama Medical Commission Halts Issuance of Integrated (and Probably Dispensary) Licenses Bradley Arant Boult Cummings LLP
Mar
27
2024
Arizona Attorney General Deems Delta-8 and Delta-10 Controlled Substances in Controversial Opinion Bradley Arant Boult Cummings LLP
Apr
18
2024
DOJ Just Said the Quiet Part Out Loud in Massachusetts Cannabis Case Bradley Arant Boult Cummings LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins